Bausch & Lomb Corp last reported quarterly results on Oct 28, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $1.4 billion (+7.3% year over year) and diluted EPS of $0.09. It usually reports 28–49 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 17, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Feb 18, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 28–49 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 28, 2026
28 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
1,375
+7.3%
|
32
+214.3%
|
0.09
+212.5%
|
|
Jul 29, 2026
29 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
1,394
+9.1%
|
-14
+77.4%
|
-0.04
+77.8%
|
|
Apr 29, 2026
29 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
1,244
+9.4%
|
-71
+66.5%
|
-0.20
+66.7%
|
|
Feb 18, 2026
49 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
1,405
+9.8%
|
-58
-1833.3%
|
-0.16
-1820.8%
|
|
Oct 29, 2025
29 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
1,281
+7.1%
|
-28
-800.0%
|
-0.08
-900.0%
|
|
Jul 30, 2025
30 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
1,278
+5.1%
|
-62
+58.9%
|
-0.18
+58.1%
|
|
Apr 30, 2025
30 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
1,137
+3.5%
|
-212
-26.9%
|
-0.60
-25.0%
|
|
Feb 19, 2025
50 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
1,280
+9.1%
|
-3
+94.4%
|
-0.01
+94.5%
|
Company profile
- Industry
- Ophthalmic Goods (SIC 3851)
- Listed as
- BLCO (NYSE)
- Fiscal year ends
- December 31
- Headquarters
- Vaughan, Ontario, Canada
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1860742
Other Ophthalmic Goods companies
- Alcon Inc ALC
- Cooper Companies, Inc. COO
- Warby Parker Inc. WRBY
- National Vision Holdings, Inc. EYE
- Staar Surgical Co STAA
- RxSight, Inc. RXST
- Innovative Eyewear Inc LUCY
Source: SEC EDGAR filings. This is company-reported data, not investment advice.